Related Experiment Video
Updated: May 5, 2026
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
Therapeutic Potential of Vanillylacetone in Ameliorating CCl4-Induced Cardiotoxicity by targeting TNF-α/ NF-κB/TGF-β1
Mohammad Firoz Alam1, Nouf A S Altowairqi1, Wedad Mawkili1
1Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, KSA.
Abstract:
The hepatotoxicity of carbon tetrachloride is widely established, although due to the paucity of research, it is not as well-known as cardiotoxicity. This research investigates the cardiotoxic effects of carbon tetrachloride in Swiss albino mice through both in vivo and in silico methodologies. Vanillylacetone is a bioactive compound found in ginger, renowned for its potent therapeutic properties, including antioxidant and anti-inflammatory effects. The present research was conducted on mice, and they were categorized into five groups (G1-G5). G1 served as a control, G2 experienced CCl4-induced toxicity, G3 and G4 were pretreated with vanillylacetone in a dose of 50 and 100 mg/kg in conjunction with CCl4, and G5 received only vanillylacetone (100 mg/kg) treatment. The results indicated that carbon tetrachloride markedly increased cardiotoxicity by elevating serum biomarkers, such as lactate dehydrogenase and creatinine kinase. Carbon tetrachloride was seen to elevate the TBARS content in cardiac tissue while diminishing antioxidant enzyme levels. Vanillylacetone is a strong antioxidant that protects the myocardium by reducing the damage that CCl4 does to the heart muscle cells. Therefore, with the findings of the results and histopathological examination, we can conclude that the treatment with vanillylacetone demonstrated a strong therapeutic effect, leading to the normalization of all serum enzyme indicators, antioxidant enzymes, and cytokines. Computational analysis indicates high binding with cardioprotective pathway components responsible for oxidative stress and inflammatory modulation, such as the TGF-β1/Smad pathway (-4.59 kcal/mol) and the NF-κB signaling pathway (-5.67 kcal/mol). These interactions suggest that vanillylacetone directly modulates cardiac damage and repair processes by multifactorial means, involving both intrinsic antioxidant scavenging and pathway modulation.
Insights
Carbon tetrachloride (CCl4) induces cardiotoxicity, but vanillylacetone, a ginger compound, offers significant cardioprotection. Vanillylacetone normalizes biomarkers and modulates key pathways, demonstrating therapeutic potential against CCl4-induced heart damage.
Area of Science:
- Pharmacology
- Toxicology
- Biochemistry
Background:
- Carbon tetrachloride (CCl4) is a known hepatotoxin with emerging evidence of cardiotoxicity.
- Research on CCl4-induced cardiotoxicity is less extensive compared to its effects on the liver.
- Vanillylacetone, a bioactive compound from ginger, possesses antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the cardiotoxic effects of CCl4 in vivo and in silico.
- To evaluate the cardioprotective potential of vanillylacetone against CCl4-induced cardiac damage.
- To elucidate the molecular mechanisms underlying vanillylacetone's protective effects.
Main Methods:
- In vivo study using Swiss albino mice divided into control, CCl4-induced toxicity, vanillylacetone pretreated groups, and vanillylacetone-only group.
- Measurement of serum biomarkers (lactate dehydrogenase, creatinine kinase) and cardiac tissue markers (TBARS, antioxidant enzymes).
- In silico computational analysis to assess vanillylacetone's binding affinity with key cardioprotective signaling pathways (TGF-β1/Smad, NF-κB).
Main Results:
- CCl4 significantly increased cardiotoxicity, evidenced by elevated serum enzymes and cardiac TBARS, alongside reduced antioxidant enzyme levels.
- Vanillylacetone pretreatment dose-dependently mitigated CCl4-induced cardiotoxicity, normalizing serum enzyme indicators, antioxidant enzymes, and cytokines.
- Computational analysis revealed strong binding of vanillylacetone to TGF-β1/Smad and NF-κB pathways, suggesting modulation of oxidative stress and inflammation.
Conclusions:
- Vanillylacetone exhibits significant cardioprotective effects against CCl4-induced cardiotoxicity in mice.
- The cardioprotection is attributed to vanillylacetone's antioxidant activity and its ability to modulate key signaling pathways involved in cardiac damage and repair.
- Vanillylacetone demonstrates therapeutic potential for managing CCl4-induced cardiotoxicity.
